Wave life sciences to present at the chardan virtual genetic medicines conference

Cambridge, mass., sept. 22, 2021 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in an analyst-led fireside chat at the chardan virtual genetic medicines conference on monday, october 4, 2021 at 2:00 p.m. et.
WVE Ratings Summary
WVE Quant Ranking